254 related articles for article (PubMed ID: 15533890)
21. Rosiglitazone causes cardiotoxicity via peroxisome proliferator-activated receptor γ-independent mitochondrial oxidative stress in mouse hearts.
He H; Tao H; Xiong H; Duan SZ; McGowan FX; Mortensen RM; Balschi JA
Toxicol Sci; 2014 Apr; 138(2):468-81. PubMed ID: 24449420
[TBL] [Abstract][Full Text] [Related]
22. Disruption of ERalpha signalling pathway by PPARgamma agonists: evidences of PPARgamma-independent events in two hormone-dependent breast cancer cell lines.
Lecomte J; Flament S; Salamone S; Boisbrun M; Mazerbourg S; Chapleur Y; Grillier-Vuissoz I
Breast Cancer Res Treat; 2008 Dec; 112(3):437-51. PubMed ID: 18204896
[TBL] [Abstract][Full Text] [Related]
23. Rosiglitazone treatment prevents mitochondrial dysfunction in mutant huntingtin-expressing cells: possible role of peroxisome proliferator-activated receptor-gamma (PPARgamma) in the pathogenesis of Huntington disease.
Quintanilla RA; Jin YN; Fuenzalida K; Bronfman M; Johnson GVW
J Biol Chem; 2008 Sep; 283(37):25628-25637. PubMed ID: 18640979
[TBL] [Abstract][Full Text] [Related]
24. Peroxisome proliferator-activated receptor gamma agonist rosiglitazone attenuates oxyhemoglobin-induced Toll-like receptor 4 expression in vascular smooth muscle cells.
Wu Y; Zhao XD; Zhuang Z; Xue YJ; Cheng HL; Yin HX; Shi JX
Brain Res; 2010 Mar; 1322():102-8. PubMed ID: 20132800
[TBL] [Abstract][Full Text] [Related]
25. Peroxisome proliferator-activated receptor-gamma agonists suppress adrenocortical tumor cell proliferation and induce differentiation.
Betz MJ; Shapiro I; Fassnacht M; Hahner S; Reincke M; Beuschlein F;
J Clin Endocrinol Metab; 2005 Jul; 90(7):3886-96. PubMed ID: 15886257
[TBL] [Abstract][Full Text] [Related]
26. Rosiglitazone, an agonist of peroxisome proliferator-activated receptor gamma, reduces pulmonary inflammatory response in a rat model of endotoxemia.
Liu D; Zeng BX; Zhang SH; Yao SL
Inflamm Res; 2005 Nov; 54(11):464-70. PubMed ID: 16307220
[TBL] [Abstract][Full Text] [Related]
27. Differential ability of a thiazolidinedione PPARgamma agonist to attenuate cytokine secretion in primary microglia and macrophage-like cells.
Woster AP; Combs CK
J Neurochem; 2007 Oct; 103(1):67-76. PubMed ID: 17573821
[TBL] [Abstract][Full Text] [Related]
28. Tobacco smoke affects expression of peroxisome proliferator-activated receptor-gamma in monocyte/macrophages of patients with coronary heart disease.
Amoruso A; Gunella G; Rondano E; Bardelli C; Fresu LG; Ferrero V; Ribichini F; Vassanelli C; Brunelleschi S
Br J Pharmacol; 2009 Nov; 158(5):1276-84. PubMed ID: 19814730
[TBL] [Abstract][Full Text] [Related]
29. Identification and characterisation of a prototype for a new class of competitive PPARγ antagonists.
Knape T; Flesch D; Kuchler L; Sha LK; Giegerich AK; Labocha S; Ferreirós N; Schmid T; Wurglics M; Schubert-Zsilavecz M; Proschak E; Brüne B; Parnham MJ; von Knethen A
Eur J Pharmacol; 2015 May; 755():16-26. PubMed ID: 25746464
[TBL] [Abstract][Full Text] [Related]
30. [Effects of peroxisome proliferator-activated receptor-gamma ligand troglitazone on colon cancer cell growth].
Koirala K; Wan YL; Liu YC; Wang X; Cui W; Wang CL; Chen HN; Wang HY; Zhu J
Beijing Da Xue Xue Bao Yi Xue Ban; 2006 Aug; 38(4):385-8. PubMed ID: 16892143
[TBL] [Abstract][Full Text] [Related]
31. Peroxisome proliferator-activated receptor gamma ligands stimulate endothelial nitric oxide production through distinct peroxisome proliferator-activated receptor gamma-dependent mechanisms.
Polikandriotis JA; Mazzella LJ; Rupnow HL; Hart CM
Arterioscler Thromb Vasc Biol; 2005 Sep; 25(9):1810-6. PubMed ID: 16020752
[TBL] [Abstract][Full Text] [Related]
32. Rescue of glandular dysmorphogenesis in PTEN-deficient colorectal cancer epithelium by PPARγ-targeted therapy.
Jagan I; Fatehullah A; Deevi RK; Bingham V; Campbell FC
Oncogene; 2013 Mar; 32(10):1305-15. PubMed ID: 22543585
[TBL] [Abstract][Full Text] [Related]
33. Anti-leukemic effects of PPARγ ligands.
Ryu S; Kim DS; Lee MW; Lee JW; Sung KW; Koo HH; Yoo KH
Cancer Lett; 2018 Apr; 418():10-19. PubMed ID: 29331412
[TBL] [Abstract][Full Text] [Related]
34. Rosiglitazone enhances fluorouracil-induced apoptosis of HT-29 cells by activating peroxisome proliferator-activated receptor gamma.
Zhang YQ; Tang XQ; Sun L; Dong L; Qin Y; Liu HQ; Xia H; Cao JG
World J Gastroenterol; 2007 Mar; 13(10):1534-40. PubMed ID: 17461445
[TBL] [Abstract][Full Text] [Related]
35. PPARγ antagonist GW9662 induces functional estrogen receptor in mouse mammary organ culture: potential translational significance.
Mehta RG; Peng X; Roy S; Hawthorne M; Kalra A; Alimirah F; Mehta RR; Kopelovich L
Mol Cell Biochem; 2013 Jan; 372(1-2):249-56. PubMed ID: 23001870
[TBL] [Abstract][Full Text] [Related]
36. PPARγ agonist rosiglitazone is neuroprotective after traumatic spinal cord injury via anti-inflammatory in adult rats.
Zhang Q; Hu W; Meng B; Tang T
Neurol Res; 2010 Oct; 32(8):852-9. PubMed ID: 20350367
[TBL] [Abstract][Full Text] [Related]
37. Peroxisome proliferator-activated receptor gamma-dependent and -independent growth inhibition of gastrointestinal tumour cells.
Rumi MA; Ishihara S; Kadowaki Y; Ortega-Cava CF; Kazumori H; Kawashima K; Yoshino N; Yuki T; Ishimura N; Kinoshita Y
Genes Cells; 2004 Nov; 9(11):1113-23. PubMed ID: 15507122
[TBL] [Abstract][Full Text] [Related]
38. Rosiglitazone, a PPARγ agonist, ameliorates palmitate-induced insulin resistance and apoptosis in skeletal muscle cells.
Meshkani R; Sadeghi A; Taheripak G; Zarghooni M; Gerayesh-Nejad S; Bakhtiyari S
Cell Biochem Funct; 2014 Dec; 32(8):683-91. PubMed ID: 25431031
[TBL] [Abstract][Full Text] [Related]
39. Rosiglitazone attenuates insulin-like growth factor 1 receptor survival signaling in PC-3 cells.
Papageorgiou E; Pitulis N; Manoussakis M; Lembessis P; Koutsilieris M
Mol Med; 2008; 14(7-8):403-11. PubMed ID: 18475308
[TBL] [Abstract][Full Text] [Related]
40. Troglitazone inhibits cell growth and induces apoptosis of B-cell acute lymphoblastic leukemia cells with t(14;18).
Takenokuchi M; Saigo K; Nakamachi Y; Kawano S; Hashimoto M; Fujioka T; Koizumi T; Tatsumi E; Kumagai S
Acta Haematol; 2006; 116(1):30-40. PubMed ID: 16809887
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
